PTCT
PTC Therapeutics Inc
$82.08
0.51 (0.63%) Today
— up— down
Market Cap
$6.77B+68.1%
Revenue (TTM)
$831.41M-53.3%
Net Income (TTM)
$372.18M-31.0%
EPS (TTM)
4.49-31.0%
Shares Out
82.95M
82.95MP/E Ratio
915.96
915.96Forward P/E
69.58
69.58Open
$81.97
$81.97Previous Close
$81.57
$81.57Day Range
$80.68 – $83.22
$80.68 – $83.2252-Week Range
$43.18 – $87.50
$43.18 – $87.50Beta
0.54
0.54Volume
1.16M
1.16MAvg Volume
1.49M
1.49MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout PTCT
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
